-Matthew A Smith Researcher Activity Profile

Research Author Detailed Information 

Matthew A Smith Publication Rate By Year

Matthew A Smith has published 1 paper(s) in 1955, 1 paper(s) in 1973, 2 paper(s) in 1981, 1 paper(s) in 1983, 1 paper(s) in 1987, 1 paper(s) in 1990, 1 paper(s) in 1995, 1 paper(s) in 1996, 1 paper(s) in 1998, 1 paper(s) in 1999, 2 paper(s) in 2000, 1 paper(s) in 2002, 2 paper(s) in 2005, 18 paper(s) in 2006, 75 paper(s) in 2007, 36 paper(s) in 2008, for a total of 145 research publications in total.

Matthew A Ma Smith Author Information

LAST NAME: smith

FIRST NAME: Matthew A

INITIALS: ma

AFFILIATION:

Papers

Matthew A Smith's Publication Record

1. Glass pattern responses in macaque V2 neurons. Year Published: 2007
Center for Neural Science, New York University, New York, NY, USA. mattsmith@cmu.edu
2. Redox metals and oxidative abnormalities in human prion diseases. Year Published: 2005
Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106, USA.
3. Adaptation and generalization in acceleration-dependent force fields. Year Published: 2006
Laboratory for Computational Motor Control, Department of Biomedical Engineering, Johns Hopkins School of Medicine, 416 Traylor Building, 720 Rutland Ave, Baltimore, MD 21205, USA.
4. Cytotoxic and genotoxic monitoring of sickle cell anaemia patients treated with hydroxyurea. Year Published: 2006
5. Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. Year Published: 2006
Roberts aboratory for NeurodegenerativeDisease Research, Sun Health Research Institute, Sun City, AZ, USA.
6. Overprescribing of lipid lowering agents. Year Published: 2006
Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, 505 WARF Bldg, 610 Walnut St, Madison, WI 53726-2397, USA. maureensmith@wisc.edu
7. Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis. Year Published: 2006
Department of Neurology, University of California, Irvine, CA 92697, USA.
8. Heme deficiency in Alzheimer's disease: a possible connection to porphyria. Year Published: 2006
9. Targeting gonadotropins: an alternative option for Alzheimer disease treatment. Year Published: 2006
10. Neurodegenerative diseases: mechanisms and therapies. Year Published: 2006
11. Oxidative damage to RNA in neurodegenerative diseases. Year Published: 2006
12. The motor-impairing effects of GABA(A) and GABA(B) agonists in gamma-hydroxybutyrate (GHB)-treated rats: cross-tolerance to baclofen but not flunitrazepam. Year Published: 2006
Department of Psychology, Davidson College, Davidson, NC 28035-7037, USA. masmith@davidson.edu
13. Hormone therapy after the Women's Health Initiative: a qualitative study. Year Published: 2006
Department of Family Medicine, Michigan State University, East Lansing, Michigan, USA. linda.french@hc.msu.edu.
14. Chronic exercise decreases sensitivity to mu opioids in female rats: correlation with exercise output. Year Published: 2006
Department of Psychology, Davidson College, Davidson, NC 28035-7037, USA. masmith@davidson.edu
15. When do older adults turn to the internet for health information? Findings from the Wisconsin Longitudinal Study. Year Published: 2006
Center for Clinical and Genetic Economics, Duke University, Durham, NC 27715, USA. kathryn.flynn@duke.edu
16. Modest copper supplementation blocks molybdenosis in cattle. Year Published: 2006
Department of Veterinary Sciences, University of Wyoming, Laramie, WY, USA.
17. Comparison of recordings from microelectrode arrays and single electrodes in the visual cortex. Year Published: 2007
Center for the Neural Basis of Cognition, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA. rkelly@cs.cmu.edu
18. Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. Year Published: 2007
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
19. Bouncing back: patterns and predictors of complicated transitions 30 days after hospitalization for acute ischemic stroke. Year Published: 2007
Department of Population Health Sciences, Wisconsin, Madison, Wisconsin, WI 53705, USA. ajk@medicine.wisc.edu
20. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. Year Published: 2007
Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
21. Increased autophagic degradation of mitochondria in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
22. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. Year Published: 2007
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH 44106, USA.
23. Early care limitations independently predict mortality after intracerebral hemorrhage. Year Published: 2007
Stroke Program, University of Michigan Medical School, Ann Arbor, MI 48109-0316, USA.
24. Signal transduction cascades associated with oxidative stress in Alzheimer's disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
25. c-Jun phosphorylation in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
26. Vascular oxidative stress in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
27. Evaluating deliberation in pediatric primary care. Year Published: 2007
Center for Women's Health Research, University of Wisconsin School of Medicine and Public Health, 610 Walnut St, Madison, WI 53726, USA.
28. Characterization of RACK1 function in Drosophila development. Year Published: 2007
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA. julie.kadrmas@hci.utah.edu
29. Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Year Published: 2007
30. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Year Published: 2007
Department of Neurology, University of California, Irvine, CA 92697, USA. tanz@uci.edu
31. Iron: the Redox-active center of oxidative stress in Alzheimer disease. Year Published: 2007
Department of Pathology, University of Maryland, Baltimore, MD, USA.
32. Trends in medical care of hospitalized stroke patients between 1980 and 1990: The minnesota stroke survey. Year Published: 2007
33. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Year Published: 2007
Hamilton Glaucoma Center and the Department of Ophthalmology, University of California San Diego, La Jolla, California 92037-0946, USA.
34. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder. Year Published: 2007
AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA. helen.winter@astrazeneca.com
35. Personality and health care decision-making style. Year Published: 2007
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA. kathryn.flynn@duke.edu
36. Proton MR spectroscopic imaging of the medulla and cervical spinal cord. Year Published: 2007
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
37. Screening for myocardial infarction and ischemic stroke: a population-based study. Year Published: 2007
Stroke Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA. devinb@umich.edu
38. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. Year Published: 2007
Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
39. Increased autophagic degradation of mitochondria in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
40. TP53 codon 72 polymorphism as a risk factor for cardiovascular disease in a Brazilian population. Year Published: 2007
41. Neuroprotective effects of caffeine against complex I inhibition-induced apoptosis are mediated by inhibition of the Atm/p53/E2F-1 path in cerebellar granule neurons. Year Published: 2007
42. The pediatric preclinical testing program: description of models and early testing results. Year Published: 2007
Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. peter.houghton@stjude.org
43. Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia. Year Published: 2007
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
44. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Year Published: 2007
Hokkaido Institute of Public Health, Kita 19, Nishi 12, Kita-ku, Sapporo 060-0819, Japan.
45. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders. Year Published: 2007
The Johns Hopkins University School of Medicine, Russell H Morgan Department of Radiology and Radiological Science, Baltimore, MD, United States.
46. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Year Published: 2007
Department of Chemistry, Asahikawa Medical College, Asahikawa 078-8510, Japan. nmasao@asahikawa-med. ac.jp
47. Emergency room staff education and use of a urinary catheter indication sheet improves appropriate use of foley catheters. Year Published: 2007
Sparrow/Michigan State University Family Medicine Residency Program, Lansing, MI.
48. Use of the CT component of PET-CT to improve PET-MR registration: demonstration in soft-tissue sarcoma. Year Published: 2007
The PET Imaging Centre, King's College London School of Medicine at St Thomas' Hospital, London, SE1 7EH, UK.
49. Bouncing-back: rehospitalization in patients with complicated transitions in the first thirty days after hospital discharge for acute stroke. Year Published: 2007
Department of Population Health Sciences, Geriatrics Division, University of Wisconsin School of Medicine and Public Health, Wadison, WI, USA. ajk@medicine.wisc.edu
50. Lesions of the dorsomedial frontal cortex block sensitization to the positive-reinforcing effects of cocaine. Year Published: 2007
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of Psychology and Program in Neuroscience, Davidson College, Davidson, NC, USA.
51. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
52. Discovery of a Tetrazole-Based Growth Hormone Secretagogue: 4-(Hydroxybutyl)carbamic Acid 2-{5-[1-(2-Amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl Ester (BMS-317180). Year Published: 2007
Departments of Discovery Chemistry, Metabolic Diease, Metabolism and Pharmacokinetics, and Process Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, Building 13, P.O. Box 5400, Princeton New Jersey 08543.
53. Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program. Year Published: 2007
St. Jude Children's Research Hospital, Memphis, Tennessee, USA. peter.houghton@stjude.org
54. Population-based analysis of the impact of expanding the time window for acute stroke treatment. Year Published: 2007
Stroke Program, University of Michigan Medical School, Ann Arbor, MI 48109-0316, USA.
55. The effect of carbodiimide blocked nucleotides on polynucleotide phosphorylase catalyzed polymerization reactions. Year Published: 1973
56. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Year Published: 2007
Department of Neurology, University of California, Irvine, CA 92697, USA. tanz@uci.edu
57. Neuroprotective effects of caffeine against complex I inhibition-induced apoptosis are mediated by inhibition of the Atm/p53/E2F-1 path in cerebellar granule neurons. Year Published: 2007
58. The pediatric preclinical testing program: description of models and early testing results. Year Published: 2007
Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. peter.houghton@stjude.org
59. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Year Published: 2007
Hokkaido Institute of Public Health, Kita 19, Nishi 12, Kita-ku, Sapporo 060-0819, Japan.
60. The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Year Published: 2007
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106 USA. mark.smith@case.edu.
61. Redox metals and oxidative abnormalities in human prion diseases. Year Published: 2005
Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106, USA.
62. IFN-{gamma} does not mimic the catabolic effects of TNF-{alpha}. Year Published: 2007
Dept. of Physiology, Univ. of Kentucky, 800 Rose St., Rm. MS-508, Lexington, KY 40536-0298. masmit8@uky.edu).
63. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. Year Published: 2007
Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
64. Emergency room staff education and use of a urinary catheter indication sheet improves appropriate use of foley catheters. Year Published: 2007
Sparrow/Michigan State University Family Medicine Residency Program, Lansing, MI.
65. Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Year Published: 2007
66. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders. Year Published: 2007
The Johns Hopkins University School of Medicine, Russell H Morgan Department of Radiology and Radiological Science, Baltimore, MD, United States.
67. Dynamics of response to perceptual pop-out stimuli in macaque v1. Year Published: 2007
Center for the Neural Basis of Cognition, Carnegie Mellon University, 4400 Fifth Avenue, Mellon Institute Room 115, Pittsburgh, PA 15213. masmith@cnbc.cmu.edu).
68. Bouncing-back: rehospitalization in patients with complicated transitions in the first thirty days after hospital discharge for acute stroke. Year Published: 2007
Department of Population Health Sciences, Geriatrics Division, University of Wisconsin School of Medicine and Public Health, Wadison, WI, USA. ajk@medicine.wisc.edu
69. Population-based analysis of the impact of expanding the time window for acute stroke treatment. Year Published: 2007
Stroke Program, University of Michigan Medical School, Ann Arbor, MI 48109-0316, USA.
70. Proton MR spectroscopic imaging of the medulla and cervical spinal cord. Year Published: 2007
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
71. Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia. Year Published: 2007
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
72. Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program. Year Published: 2007
St. Jude Children's Research Hospital, Memphis, Tennessee, USA. peter.houghton@stjude.org
73. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. Year Published: 2008
Department of Surgery, University of Virginia Health System, Charlottesville 22908-0679, USA. bdk8g@virginia.edu
74. Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180). Year Published: 2007
Department of Discovery Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, NJ 08543, USA. jun.li@bms.com
75. IFN-gamma does not mimic the catabolic effects of TNF-alpha. Year Published: 2007
Department of Physiology, University of Kentucky, Lexington, KY 40536-0298, USA. masmit8@uky.edu
76. The role of voltage-gated potassium channels in the regulation of mouse uterine contractility. Year Published: 2008
epartment of Pharmacology, Creighton University Medical Center, Omaha, USA, NE 68178, USA. rcsmith@creighton.edu
77. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Year Published: 2007
Hokkaido Institute of Public Health, Kita 19, Nishi 12, Kita-ku, Sapporo 060-0819, Japan.
78. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Year Published: 2007
Department of Chemistry, Asahikawa Medical College, Asahikawa 078-8510, Japan. nmasao@asahikawa-med. ac.jp
79. Synovial sarcoma mimicking haemophilic pseudotumour. Year Published: 2008
Department of Trauma & Orthopaedics, Royal Free Hampstead NHS Trust, London NW2 5QX, UK.
80. The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA. mark.smith@case.edu
81. SK-NEP-1 and Rh1 are Ewing family tumor lines. Year Published: 2008
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA. smithm@ctep.nci.nih.gov
82. Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program. Year Published: 2008
Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine and Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania, USA. maris@chop.edu
83. Tunable diode laser measurements of air-broadened linewidths in the [ngr ]6 band of H2O 2. Year Published: 2008
84. Absolute intensities and self-, N2-, and air-broadened Lorentz halfwidths for selected lines in the nu3 band of 12CH3D from measurements with a tunable diode laser spectrometer. Year Published: 2008
85. Cytotoxic and genotoxic monitoring of sickle cell anaemia patients treated with hydroxyurea. Year Published: 2006
86. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder. Year Published: 2007
AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA. helen.winter@astrazeneca.com
87. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. Year Published: 2008
Department of Experimental Medicine and Oncology, University of Torino, Torino, Italy. elena.tamagno@unito.it
88. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology. Year Published: 2008
Department of Cell Biology, CINVESTAV-IPN, Mexico City, Mexico.
89. The role of novel chitin-like polysaccharides in Alzheimer disease. Year Published: 2008
Department of Pathology, University of Maryland, Baltimore, MD 21201, USA; Department of Pathology, Case Western Reserve University, Cleveland, OH; College of Sciences, University of Texas at San Antonio, San Antonio, TX, USA.
90. Bouncing back: patterns and predictors of complicated transitions 30 days after hospitalization for acute ischemic stroke. Year Published: 2007
Department of Population Health Sciences, Wisconsin, Madison, Wisconsin, WI 53705, USA. ajk@medicine.wisc.edu
91. Use of the CT component of PET-CT to improve PET-MR registration: demonstration in soft-tissue sarcoma. Year Published: 2007
The PET Imaging Centre, King's College London School of Medicine at St Thomas' Hospital, London, SE1 7EH, UK.
92. Bouncing-back: rehospitalization in patients with complicated transitions in the first thirty days after hospital discharge for acute stroke. Year Published: 2007
Department of Population Health Sciences, Geriatrics Division, University of Wisconsin School of Medicine and Public Health, Wadison, WI, USA. ajk@medicine.wisc.edu
93. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Year Published: 2008
Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109-2216, USA. klionsky@umich.edu
94. Oxidative stress and neurotoxicity. Year Published: 2008
Departments of Chemistry, Pathology, and Environmental Health Sciences, Case Western Reserve University, Cleveland, Ohio 44106, and College of Sciences, University of Texas at San Antonio, San Antonio, Texas 78249 LMS3@case.edu.
95. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
96. Ultrastructural analysis of chemical synapses and gap junctions between Drosophila brain neurons in culture. Year Published: 2008
Department of Anatomy and Neurobiology, University of California, Irvine, California 92697-1280.
97. Personality and health care decision-making style. Year Published: 2007
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA. kathryn.flynn@duke.edu
98. Dose-response model for Listeria monocytogenes-induced stillbirths in nonhuman primates. Year Published: 2008
Department of Environmental Health Science, College of Public Health, University of Georgia, 206 Environmental Health Science Bldg., Athens, GA 30602-2102, USA. masmith@uga.edu
99. Measurements of 12CH4 nu4 band halfwidths using a tunable diode laser system and a Fourier transform spectrometer. Year Published: 2008
100. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. Year Published: 2008
Department of Psychiatry and Neurology, Asahikawa Medical College, Asahikawa 078-8510, Japan. nuno@asahikawa-med.ac.jp.
101. Oxidative RNA damage and neurodegeneration. Year Published: 2008
Department of Psychiatry and Neurology, Asahikawa Medical College, Higashi 2-1-1-1, Midorigaoka, Asahikawa 078-8510, Japan. nuno@asahikawa-med.ac.jp.
102. Evidence for the role of luteinizing hormone in Alzheimer disease. Year Published: 2008
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA. mark.smith@case.edu.
103. Increased autophagic degradation of mitochondria in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
104. Evidence for the role of luteinizing hormone in Alzheimer disease. Year Published: 2008
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA.
105. Measurement of pharmacokinetic parameters in histologically graded invasive breast tumours using dynamic contrast-enhanced MRI. Year Published: 2008
Academic Unit of Medical Physics, University of Leeds, Leeds, UK. sasha@medphysics.leeds.ac.uk
106. Assessment of the physician-caregiver relationship scales (PCRS). Year Published: 2007
Center for Women's Health Research, University of Wisconsin School of Medicine and Public Health, United States.
107. Cytotoxic and genotoxic monitoring of sickle cell anaemia patients treated with hydroxyurea. Year Published: 2006
Centro de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, Brazil.
108. Screening for myocardial infarction and ischemic stroke: a population-based study. Year Published: 2007
Stroke Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA. devinb@umich.edu
109. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. Year Published: 2008
Department of Surgery, University of Virginia Health System, Charlottesville 22908-0679, USA. bdk8g@virginia.edu
110. The role of voltage-gated potassium channels in the regulation of mouse uterine contractility. Year Published: 2008
epartment of Pharmacology, Creighton University Medical Center, Omaha, USA, NE 68178, USA. rcsmith@creighton.edu
111. Dynamics of response to perceptual pop-out stimuli in macaque V1. Year Published: 2007
Center for the Neural Basis of Cognition, Carnegie Mellon University, Mellon Institute, Pittsburgh, PA 15213, USA. masmith@cnbc.cmu.edu
112. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
113. The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA. mark.smith@case.edu
114. Oxidative RNA damage and neurodegeneration. Year Published: 2008
Department of Psychiatry and Neurology, Asahikawa Medical College, Higashi 2-1-1-1, Midorigaoka, Asahikawa 078-8510, Japan. nuno@asahikawa-med.ac.jp
115. Use of the CT component of PET-CT to improve PET-MR registration: demonstration in soft-tissue sarcoma. Year Published: 2007
The PET Imaging Centre, King's College London School of Medicine at St Thomas' Hospital, London, SE1 7EH, UK.
116. SK-NEP-1 and Rh1 are Ewing family tumor lines. Year Published: 2008
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA. smithm@ctep.nci.nih.gov
117. Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program. Year Published: 2008
Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine and Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania, USA. maris@chop.edu
118. Positron emission tomography and the orthopaedic surgeon. Year Published: 2000
Department of Orthopaedics, Guy's Hospital, London, UK.
119. Functional imaging and the orthopaedic surgeon. Year Published: 2002
Department of Nuclear Medicine, Guy's and St Thomas' Hospital, London, England, UK.
120. The surgical management of varus deformity in haemophilic arthropathy of the knee. Year Published: 1981
121. Glomus tumours of the coccygeal body associated with coccydynia. A preliminary report. Year Published: 1981
122. Interposition arthroplasty in the management of advanced haemophilic arthropathy of the elbow. Year Published: 1983
123. Prediction of fracture healing in the tibia by quantitative radionuclide imaging. Year Published: 1987
124. Silastic interposition for haemophilic arthropathy of the elbow. Year Published: 1990
St. Thomas's Hospital, London, England.
125. Supramalleolar tibial osteotomy for haemophilic arthropathy of the ankle. Year Published: 1995
St Thomas' Hospital, London, England.
126. Surgical resection of primary soft-tissue sarcoma. Incidence of residual tumour in 95 patients needing re-excision after local resection. Year Published: 1996
St. Thomas' Hospital, London, England.
127. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. Year Published: 1998
UMDS and Guy's and St Thomas' Hospital Trust, St Thomas' Hospital, London, England, UK.
128. Sprain of the pisiformtriquetral joint; report of six cases. Year Published: 1955
129. Neuroprotective effects of caffeine against complex I inhibition-induced apoptosis are mediated by inhibition of the Atm/p53/E2F-1 path in cerebellar granule neurons. Year Published: 2007
Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Universitat de Barcelona, Nucli Universitari de Pedralbes, Barcelona, Spain.
130. Quantitative comparison of intrabrain diffusion in adults and preterm and term neonates and infants. Year Published: 2000
Department of Medical Physics and Centre of Medical Imaging Research, University of Leeds, Leeds General Infirmary, United Kingdom.
131. Adaptation and generalization in acceleration-dependent force fields. Year Published: 2006
Laboratory for Computational Motor Control, Department of Biomedical Engineering, Johns Hopkins School of Medicine, 416 Traylor Building, 720 Rutland Ave, Baltimore, MD 21205, USA.
132. Dissociable effects of the implicit and explicit memory systems on learning control of reaching. Year Published: 2006
Laboratory for Computational Motor Control, Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
133. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. Year Published: 2008
Department of Experimental Medicine and Oncology, University of Torino, Torino, Italy. elena.tamagno@unito.it
134. Dose-response model for Listeria monocytogenes-induced stillbirths in nonhuman primates. Year Published: 2008
Department of Environmental Health Science, College of Public Health, University of Georgia, 206 Environmental Health Science Bldg., Athens, GA 30602-2102, USA. masmith@uga.edu
135. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. Year Published: 2008
College of Sciences, University of Texas at San Antonio, San Antonio, Texas 78249, USA. george.perry@utsa.edu.
136. Role of oxidative stress in frontotemporal dementia. Year Published: 1999
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
137. Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program. Year Published: 2008
St. Jude Children's Research Hospital, Memphis, Tennessee, USA. peter.houghton@stjude.org
138. Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders. Year Published: 2008
Clinical Pharmacokinetics, Clinical Pharmacology, Astra-Zeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE 19850, USA.
139. Identifying Persons with Treated Asthma Using Administrative Data via Latent Class Modelling. Year Published: 2008
Pharmaceutical Outcomes Programme, Children's and Women's Health Centre of British Columbia, University of British Columbia, 4480 Oak Street, Room B404, Vancouver, BC, Canada V6H 3V4.
140. Characterizing hospice services in the United States. Year Published: 2008
Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, 505 WARF Building, 610 Walnut Street, Madison, WI 53726. maureensmith@wisc.edu.
141. Initial testing of cisplatin by the pediatric preclinical testing program. Year Published: 2008
Children's Cancer Institute Australia for Medical Research, Randwick, New South Wales, Australia.
142. IFN-gamma does not mimic the catabolic effects of TNF-alpha. Year Published: 2007
Department of Physiology, University of Kentucky, Lexington, KY 40536-0298, USA. masmit8@uky.edu
143. Evidence for the role of luteinizing hormone in Alzheimer disease. Year Published: 2008
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA.
144. Nucleic acid oxidation in Alzheimer disease. Year Published: 2008
Center for Neuroscience and Cell Biology, Institute of Physiology-Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
145. Integrin regulation of cytoplasmic calcium in excitatory neurons depends upon glutamate receptors and release from intracellular stores. Year Published: 2008
Department of Anatomy and Neurobiology, University of California, Irvine CA 92697-4292, USA.